This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

October 19-22, 2020
Now Delivered 100% Virtually,
(All-Digital Format)

THE EUROPEAN CELL AND GENE THERAPY CONGRESS FOR GROUND BREAKING MANUFACTURING, COMMERCIALISATION & SUPPLY CHAIN STRATEGIES

World renowned leaders share the latest analytical techniques & vector technologies to revolutionize your cell, gene & gene edited ex vivo cell therapy programs

For 2020, we have decided to combine our EU and US meetings into one GLOBAL virtual event. Redefining your learning experience and bringing the content you want, when you want it.

NEWS FLASH: BRAND NEW GLOBAL 2020 VIRTUAL EVENT!

In light of the current global climate, it is more important than ever for the cell & gene therapy community to connect with one another, strategize and share ideas – All in a safe, responsible way. With our dedication to address the most pressing issues, our cell and gene therapy events, now taking place October 19 - 22, have undergone a timely transformation, moving to an all-digital format and offering attendees the ability to participate in virtual content, exhibits and networking opportunities.



Stream 1: Cell Therapy
Stream 1: Cell Therapy
  • Push the boundaries of process development with novel considerations & strategies
  • Transition to a more standardizes approach to raw material selection & supply
  • Improve confidence in your supply chain with next generation manufacturing and cryo techniques
Stream 2: Gene Edited Ex Vivo Cell Therapy
Stream 2: Gene Edited Ex Vivo Cell Therapy
  • Build a strategy for next generation allogeneic CAR & T cell therapies
  • Get to grips with different manufacturing infrastructures & commercialization strategies
  • Understand effective testing, characterization & validation approaches
Stream 3: In Vivo Gene Therapy
Stream 3: In Vivo Gene Therapy
  • Optimize next generation cell lines and address the current challenges with viral vectors
  • Work towards continuous bioprocessing of vectors with enabling manufacturing tech
  • Ensure high throughput applications in downstream processing

WHICH ONE WOULD YOU CONSIDER YOURSELF TO BE....?


I am a Pioneer
I am a Pioneer

- An innovator who has been in the industry since conception and wants to put theory into practice

Why should I attend?

- Hear from small emerging biotechs who are pitching big ideas

- Hear from small emerging biotech's who are pitching big ideas

- Benchmark, network & meet peers and tech providers through the one-to-one meeting tool

I am STILL LEARNING
I am STILL LEARNING

- Fairly new to the cell and gene therapy community with previous experience with MAb's and other modalities

Why should I attend?

- Hear how the industry think to apply my experience in the space

- Understand the industry landscape and where the gaps lie

- Have the opportunity for exposure, collaboration and success

I am a PROBLEM SOLVER
I am a PROBLEM SOLVER

- I bring thought leadership to the table I have a clear definition of what the industry issues are

Why should I attend?

- Get access to all the key stakeholders in industry

- Gain authority in the field through building my personal brand

- Get an unrivaled opportunity to present cutting edge scientific data

CONNECT WITH KEY BUYERS AT CELL THERAPY VIRTUAL

Whether you're increasing your company profile, launching a new product or focusing on new business development opportunities, collaborate with us to identify custom solutions to help you reach your goals.  

Contact Perri Lucatello: Perri.Lucatello@informa.com | +44 (0)20 7017 7247 


PRESS REGISTRATION & GUIDELINES

Get the latest event updates

Sign up to get the latest event updates and information.